Azienda Ospedaliera Santa Maria Terni-SC Oncologia ( Site 0900)
Terni 05100
0 studies enrolling now · 1 studies all time
What they study most
Renal Cell Carcinoma
Studies at this site
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
— Completed